Etodolac, a Selective Cyclooxygenase-2 Inhibitor, Inhibits Liver Metastasis of Colorectal Cancer Cells via the Suppression of MMP-9 Activity

International Journal of Molecular Medicine - Greece
doi 10.3892/ijmm.17.2.357
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

TIMP-2 Inhibits Metastasis and Predicts Prognosis of Colorectal Cancer via Regulating MMP-9

Cell Adhesion and Migration
Molecular NeuroscienceCell BiologyCellular
2019English

Antiangiogenic Activity of the Selective Cyclooxygenase 2 Inhibitor Rofecoxib in Human Colorectal Cancer Liver Metastases

Gut
Gastroenterology
2006English

RUNX3 Inhibits the Invasion and Metastasis of Human Colon Cancer HT-29 Cells by Upregulating MMP-2/9

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2020English

Sinomenine Inhibits Proliferation of SGC-7901 Gastric Adenocarcinoma Cells via Suppression of Cyclooxygenase-2 Expression

Oncology Letters
Cancer ResearchOncology
2011English

Membranous Nephropathy Associated With the Relatively Selective Cyclooxygenase-2 Inhibitor, Etodolac, in a Patient With Early Rheumatoid Arthritis

Internal Medicine
Internal MedicineMedicine
2007English

PinX1 Inhibits the Invasion and Metastasis of Human Breast Cancer via Suppressing NF-κB/MMP-9 Signaling Pathway

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2015English

Sodium Fluoride Inhibits MMP-2 and MMP-9

Journal of Dental Research
Dentistry
2013English

Antitumor Activity of the Selective Cyclooxygenase-2 Inhibitor, Celecoxib, on Breast Cancer in Vitro and in Vivo

Cancer Cell International
Cancer ResearchOncologyGenetics
2012English

miR-21 Inhibits the Effects of Cyclooxygenase-2 Inhibitor NS398 on Apoptosis and Invasion in Gastric Cancer Cells

OncoTargets and Therapy
OncologyPharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy